Danish Covid-19 therapy shows promise in phase I trial
![Photo: Union Therapeutics / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12882280.ece/ALTERNATES/schema-16_9/doc7f8xts9m1g81hwiccikh.jpg)
Biotech company Union Therapeutics is excited about positive preliminary trial data involving the company's niclosamide nasal spray, which it hopes will have an efficient impact on kidney patients with Covid-19.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.